Open Access

Genomic amplification of HPV, h‑TERC and c‑MYC in liquid‑based cytological specimens for screening of cervical intraepithelial neoplasia and cancer

  • Authors:
    • Wenting Ji
    • Weihua Lou
    • Zubei Hong
    • Lihua Qiu
    • Wen Di
  • View Affiliations

  • Published online on: December 12, 2018     https://doi.org/10.3892/ol.2018.9825
  • Pages: 2099-2106
  • Copyright: © Ji et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cervical cancer is one of the most prevalent female cancer types in developing countries. ThinPrep cytological test (TCT) and human papillomavirus (HPV) detection are canonical screening methods for cervical cancer currently. However, there are limitations to these techniques. The aim of the present study was to identify efficient and practical methods for the screening of cervical intraepithelial neoplasia (CIN) and carcinoma. Residual PreservCyt specimens were obtained from 1,000 women who were admitted between August 2013 and December 2015. TCT, human telomerase RNA component (h‑TERC) fluorescent in situ hybridization (FISH), MYC‑specific FISH and surface plasmon resonance (SPR)‑HPV genotyping were performed, followed by histopathology for those patients with positive results in any of the four tests. As a result, 106, 64, 56 and 112 patients were positive in the TCT, h‑TERC, c‑MYC and SPR‑HPV tests, respectively, resulting in 213 being scheduled for histopathology; inflammation was identified in 159 patients, CIN I in 31, CIN II in 14, CIN III in seven and invasive cervical cancer in two patients. Using histopathology as the gold standard, TCT exhibited the highest sensitivity (87.04%), while h‑TERC analysis had the highest specificity (81.76%). Parallel tests demonstrated that the Youden's index of TCT + h‑TERC was the highest (0.49), while the serial analysis reported that TCT + HPV had the highest Youden's index (0.53) compared with any of the biomarkers alone (TCT, 0.50; HPV, 0.29; h‑TERC, 0.47). In conclusion, dual positive TCT and HPV may be an efficient approach for basic screening of cervical lesions. h‑TERC amplification may serve as an auxiliary test to improve the specificity.
View Figures
View References

Related Articles

Journal Cover

February-2019
Volume 17 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ji W, Lou W, Hong Z, Qiu L and Di W: Genomic amplification of HPV, h‑TERC and c‑MYC in liquid‑based cytological specimens for screening of cervical intraepithelial neoplasia and cancer. Oncol Lett 17: 2099-2106, 2019.
APA
Ji, W., Lou, W., Hong, Z., Qiu, L., & Di, W. (2019). Genomic amplification of HPV, h‑TERC and c‑MYC in liquid‑based cytological specimens for screening of cervical intraepithelial neoplasia and cancer. Oncology Letters, 17, 2099-2106. https://doi.org/10.3892/ol.2018.9825
MLA
Ji, W., Lou, W., Hong, Z., Qiu, L., Di, W."Genomic amplification of HPV, h‑TERC and c‑MYC in liquid‑based cytological specimens for screening of cervical intraepithelial neoplasia and cancer". Oncology Letters 17.2 (2019): 2099-2106.
Chicago
Ji, W., Lou, W., Hong, Z., Qiu, L., Di, W."Genomic amplification of HPV, h‑TERC and c‑MYC in liquid‑based cytological specimens for screening of cervical intraepithelial neoplasia and cancer". Oncology Letters 17, no. 2 (2019): 2099-2106. https://doi.org/10.3892/ol.2018.9825